Effectiveness of cisplatin monotherapy in standard-risk hepatoblastoma

Q4 Medicine

Pediatric Hematology/Oncology and Immunopathology Pub Date : 2022-12-26 DOI:10.24287/1726-1708-2022-21-4-31-44

R. Moiseenko, D. Akhaladze, A. Filin, E. F. Kim, G. Rabaev, E. Feoktistova, N. Merkulov, A. V. Metelin, G. Tereshchenko, V. V. Shchukin, T. Shamanskaya, S. Varfolomeeva, D. Kachanov

引用次数: 1

查看原文本刊更多论文

顺铂单药治疗标准风险肝母细胞瘤的疗效

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Pediatric Hematology/Oncology and Immunopathology Medicine-Pediatrics, Perinatology and Child Health

CiteScore

0.40

自引率

0.00%

发文量